In order to recommend cannabis in Tennessee, you must be a physician affiliated with clinical research on treatment for intractable seizures that is being conducted through a university school of medicine. Recommending clinicians must supply a report to the Commissioner of Health and Tennessee's General Assembly by January 2018 on the results of all cannabis research, including the number of patients involved, the parameters of the study and the outcomes of each participant. Below is a basic overview of state requirements and links to other educational resources.

Qualifying Medical Conditions:

Individuals who have the following medical conditions can possess CBD oil containing less than 0.9% of THC:

  • Alzheimer’s disease
  • Amyotrophic lateral sclerosis (ALS)
  • Cancer, when such disease is diagnosed as end-stage or the treatment produces related wasting illness, nausea and vomiting, or pain
  • Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis
  • Epilepsy or seizures
  • Multiple sclerosis
  • Parkinson’s disease
  • Human immunodeficiency virus (HIV)
  • acquired immunodeficiency syndrome (AIDS)
  • Sickle cell disease

Medical professionals have a legal right to recommend cannabis as a treatment in any state, as protected by the First Amendment. Established by a 2004 United States Supreme Court decision to uphold earlier federal court rulings that found doctors and their patients have a fundamental Constitutional right to freely discuss treatment options.

 More resources for medical professionals can be found here.